Lisdexamfetamine Dimesylate
NDC 0054-0660, lisdexamfetamine dimesylate, capsule, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0660
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202827
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0660 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE10 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0660-25 | 00054066025 | 100 CAPSULE in 1 BOTTLE (0054-0660-25) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6740a621-9bec-4178-a4fc-a3fc89f34e0aNADAC price for package 00054066025
GET /v1/drugs/nadac/00054066025
Use it
Look up 0054-0660 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0660 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0660. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.